Literature DB >> 8268557

In vivo verification of an automatic noninvasive system for real time Kt evaluation.

H Steil1, A M Kaufman, A T Morris, N W Levin, H D Polaschegg.   

Abstract

It is generally accepted that morbidity and mortality of hemodialysis patients is related to dialysis quantitation. Currently available methods for the quantitation of dialysis require blood sampling or a continuous measurement of changes in urea concentration during treatment. These maneuvers are time consuming and expensive, and are generally performed, at most, once per month. The authors introduce an on-line, automated method for measurement of dialyzer electrolyte clearance comparable to urea clearance by using dialysate conductivity sensors placed pre and post dialyzer, and measuring conductivity at three different pre dialyzer levels. Conditions that reduce clearance, such as recirculation or fiber clotting, are automatically taken into account so that the method measures effective clearance rather than dialyzer clearance. In vitro and in vivo studies validate the method. Results are immediately available and can be used to address problems such as improper needle placement and access recirculation. In addition, repetitive electrolyte clearance data can serve to enhance quality assurance programs with respect to verifying the function of reused or new dialyzers. Appropriate algorithms can be used to calculate delivered Kt/V.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8268557

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  2 in total

Review 1.  On-line dialyser clearance using conductivity.

Authors:  H D Polaschegg
Journal:  Pediatr Nephrol       Date:  1995       Impact factor: 3.714

2.  Efficacy of dialysis in peritoneal dialysis: utility of bioimpedance to calculate Kt/V and the search for a target Kt.

Authors:  G Martínez Fernández; A Ortega Cerrato; J Masiá Mondéjar; A Pérez Rodríguez; F Llamas Fuentes; C Gómez Roldán; Juan Pérez-Martínez
Journal:  Clin Exp Nephrol       Date:  2012-08-11       Impact factor: 2.801

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.